We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Chinese AI System Designed to Predict Diabetes Years in Advance

By HospiMedica International staff writers
Posted on 24 Sep 2018
4 Paradigm (Beijing, China), a technology company, is working with Ruijin Hospital (Shanghai, China) to develop a new artificial intelligence (AI) system that will help them to identify patients at risk of developing diabetes up to 15 years in advance. The model named Ruining Knows Sugar, or Ruining Zhitang in Chinese, has achieved an accuracy rate of 88% in tests.

Designed to identify those most at risk of developing type 2 diabetes within the next three years, the system also provided risk forecasts for the next nine and 15 years as a reference. For the tests, the new system used medical information from 170,000 individuals from across the country, some of who had diabetes and others did not. The data collected by the hospital’s diabetes research team between 2010 and 2013 included gender, height, weight, blood sugar levels, smoking and drinking history, and education levels. The AI algorithm then used that information to make its predictions and “learned” from the results.

The use of AI to help predict and monitor diabetes is growing. For instance, in June 2018, medical device company Medtronic along with IBM Waston Health released its Sugar.IQ app, which evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines.

Related Links:
4 Paradigm
Ruijin Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Fetal and Maternal Monitor
F9 Series
New
Vertebral Body Replacement System
Hydrolift

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex